Researchers have identified a new subtype of lymphoma which could pave the way to improved and more targeted treatments for ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

Hundreds more people with an aggressive form of blood cancer can now be offered hope of a cure and “a new lease of life” from today thanks to an NHS drug rollout.

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved and more targeted treatments for some blood cancer patients.

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...

Swiss pharma major Roche (ROG: SIX) has welcomed positive final draft guidance from the UK's health technology assessor, NICE ...

New methods of classifying patients could pave the way for more personalized treatment approaches, a new report states. The methods of subtyping diffuse large B-cell lymphoma (DLBCL) have changed over ...

Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...

—This large, population-based study of patients with PP-DLBCL assessed prognostic factors and confirmed that certain common therapeutic interventions can modify disease progression. Being age 65 years ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this ...

—For medical teams tasked with caring for patients with diffuse large B-cell lymphoma, progression or relapse that involves the central nervous system can be extremely challenging and potentially life ...